Email ID
Password
Scrip   
Addex and Merck & Co extend Parkinson's disease collaboration
02 December 2009
Sukaina Virji

Addex Pharmaceuticals of Switzerland and Merck & Co have extended by a year the research stage of their collaboration to develop a treatment for Parkinson's disease and other indications.

The collaboration is focused on developing positive allosteric modulators (PAM) of the metabotropic...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36